English | Español
Patient Daily | Apr 10, 2026

Biotech IPOs rebound as AI becomes central in drug development
Patient Daily | Apr 10, 2026

Ambrosia Biosciences raises $100 million to develop small-molecule GLP-1 obesity drugs
Patient Daily | Apr 10, 2026

Novo Nordisk to lay off 400 workers at Bloomington plant despite ongoing investment
Patient Daily | Apr 10, 2026

Trump’s MFN pricing expected to delay more European drug launches
Patient Daily | Apr 10, 2026

Researchers develop heat-activated patch for noninvasive melanoma treatment in mice
Patient Daily | Apr 10, 2026

Study links mononucleosis infection to higher risk of multiple sclerosis
Patient Daily | Apr 10, 2026

Researchers identify molecule that may slow progression of brain diseases
Patient Daily | Apr 10, 2026

NIH awards $15.85 million to UC Davis Health for Latino brain aging study

Trending
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Researchers identify artemin as marker and target in feline osteoarthritis
+ Pharmaceuticals
Patient Daily | Apr 11, 2026

Remote monitoring technology helps Brooklyn resident manage high blood pressure